AAAAAA
Results:
1-9
|
Results: 9
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Mabro, M
Artru, P
Gilles, V
Lotz, JP
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7), EUR J CANC, 37(8), 2001, pp. 1000-1005
Authors:
Artru, P
Tournigand, C
Mabro, M
Lucchi, E
Louvet, C
De Gramont, A
Krulik, M
Citation: P. Artru et al., Primary hyperparathyroidism associated with colon cancer, GASTRO CL B, 25(2), 2001, pp. 208-209
Authors:
Louvet, C
de Gramont, A
Tournigand, C
Artru, P
Maindrault-Goebel, F
Krulik, M
Citation: C. Louvet et al., Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma, CANCER, 91(11), 2001, pp. 2033-2038
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles, V
Lotz, JP
Tournigand, C
Mabro, M
Molitor, JL
Artru, P
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer, ANN ONCOL, 11(11), 2000, pp. 1477-1483
Authors:
Bechade, D
Algayres, JP
Baranger, B
Arborio, M
Louvet, C
Krulik, M
Bili, H
Coutant, G
Daly, JP
Citation: D. Bechade et al., Malignant peritoneal mesothelioma revealed by small bowel obstruction, GASTRO CL B, 24(12), 2000, pp. 1237-1240
Authors:
Maindrault-Goebel, F
Louvet, C
Andre, T
Carola, E
Lotz, JP
Molitor, JL
Garcia, ML
Gilles-Amar, V
Izrael, V
Krulik, M
de Gramont, A
Citation: F. Maindrault-goebel et al., Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6), EUR J CANC, 35(9), 1999, pp. 1338-1342
Authors:
Andre, T
Louvet, C
Maindrault-Goebel, F
Couteau, C
Mabro, M
Lotz, JP
Gilles-Amar, V
Krulik, M
Carola, E
Izrael, V
de Gramont, A
Citation: T. Andre et al., CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer, EUR J CANC, 35(9), 1999, pp. 1343-1347
Authors:
Mabro, M
Gilles-Amar, V
Louvet, C
Carola, E
Maindrault-Goebel, F
de Gramont, A
Krulik, M
Citation: M. Mabro et al., Bimonthly fluorouracil in elderly patients with metastatic colorectal cancer: a report of 50 patients., REV MED IN, 20(10), 1999, pp. 863-868
Authors:
Krulik, M
Citation: M. Krulik, Prologue, PRESSE MED, 27(39), 1998, pp. 2105-2105
Risultati:
1-9
|